The nonobese diabetic (NOD)' mouse is a model of human type I diabetes mellitus (1-4) . The diabetic processes that occur in both species appear to reflect an autoimmune response to the insulin-producing Q cells within the islets of the pancreas (5-7). Helper and cytotoxic T lymphocytes are found within the affected islets in the NOD mouse (6, 8) . We (9) , and Bendelac et al. (10) , have recently demonstrated that both the CD4 and CD8 T cell subsets are necessary to transfer diabetes in the NOD mouse. As in man, diabetes in the NOD mouse is controlled by multiple genetic loci, including one that is linked to, or is located within, the MHC (11) (12) (13) . Although the stimulus for the induction of an autoimmune response in the NOD mouse is still unknown, periductal and perivascular infiltrates and insulitis are observed within the pancreas beginning at 3-5 wk of age (2, 3) .
To determine whether the primary genetic defect that causes insulitis and diabetes in the NOD mouse resides in the immune system or, alternatively, in the tissue that is the target of the autoimmune response, we have initiated a series of studies using irradiated (NOD x B10)F1 mice that have been reconstituted with NOD bone marrow cells. (NOD x B10)F, mice do not develop diabetes or display insulitis (12) . In addition, since (NOD x B10)F, mice are semisyngeneic at the MHC with the transferred NOD bone marrow cells, an efficient immune response can be mounted in the chimeras . In this study, we demonstrate that a majority of irradiated (NOD x B10)F, mice that receive NOD bone marrow cells develop insulitis and some become diabetic . These NOD--, chimeras not only destroy their own a cells but also reject the R cells present in transplanted pancreata obtained from newborn NOD and 1310 mice. These data indicate that the genetically determined insulitis and diabetes present in NOD mice are expressed at the level ofthe hematopoietic stem cells.
Materials and Methods
Animals. An NOD (Kd, I-A 101 , Db) breeding nucleus was kindly provided by Dr. Yoshihiro Tochino (Aburabi Laboratories, Shionogi and Co., Osaka, Japan) and C57B1/I0SnJ (B10) (Kb, I-Ab, Db) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) . (NOD x BI0)F, mice were bred in our animal facility in Rahway, NJ . Mice used in this study were housed under specific pathogen-free conditions .
Preparation and Analysis of Chimeras. Bone marrow cells were harvested from 5-7-wk-old female donors . To remove mature T cells, bone marrow cells were incubated at 4°C for 30 min with a mixture of T cell-specific mAbs : anti Thy-1 .2 (HO-13-4) (14) (TIB 99, American Type Culture Collection, Rockville, MD), anti-Lyt-1 .2 (C3PO.13) (15) (kindly provided by Dr. Eli Sercarz, University of California at Los Angeles), and anti-Lyt-2 (3 .155) (16) (TIB 211, ATCC) . The cells were then incubated with absorbed guinea pig complement at 37°C for 40 min. 5-7-wk-old females were irradiated (1,000 rad from a "'Cesium source, Gammacell 40, Atomic Energy of Canada, Ltd ., Ottawa, Ontario) and injected intravenously with 10-20 x 10 6 bone marrow cells . Chimeras are designated as bone marrow donor-irradiated recipient . For example, an irradiated F, recipient that has received NOD bone marrow is represented as NOD-F l .
After a period of at least 2 mo, representative chimeras from each group were tested for their extent of chimerism . Spleen cells from chimeras were typed with class I-and class IIspecific antibodies : anti-Kb . q, Dd, H-2' (34-4-20S) (17) (Litton Bionetics, Charleston, SC), anti-Kd (2 . Normal and chimeric mice were monitored for the development of diabetes by testing for urinary glucose with TesTape (Eli Lilly, Indianapolis, IN) . Animals were classified as diabetic after producing consistent TesTape values of 1+ or higher. To allow sufficient time for the development of insulitis and/or diabetes, normal animals were killed at 7 mo old or older, and chimeras were killed no sooner than 7 mo after construction . Some chimeras were allowed to reach the age of 17 mo post-construction .
Neonatal Pancreas Transplantation . Selected NOD-F, chimeras received transplants of pancreata (20) obtained from NOD and B10 mice that were <24 h old . Each host received three pancreata from newborn NOD mice under one renal capsule and three pancreata from newborn B10 mice under the other renal capsule.
Histology . Pancreata were excised and fixed in buffered 10% formalin and processed for paraffin sectioning . Tissue sections (5 gm) were stained with hematoxylin and eosin and microscopically evaluated for the presence of mononuclear cell infiltration . Histological specimens were interpreted without knowledge of the treatment. Three noncontiguous sections of each pancreas (45-50 gm between sections) were examined . Animals received a positive score for insulitis if infiltrating mononuclear cells were observed within islets . Frozen sections of pancreata were prepared for immunohistochemical staining of the L3T4 and Lyt-2 T cell subsets . Ascites fluid containing anti-L3T4 antibodies (GK1 .5) (21) was prepared as previously described (9) and anti-Lyt-2 antibodies were obtained from Becton Dickinson & Co . Sections were developed using the Vectastain ABC kit specific for rat IgG (Vector Laboratories, Inc., Burlingame, CA) .
4-5 wk after transplantation, chimeras that received pancreas grafts were killed, and the grafts were fixed in buffered 10 01c formalin and embedded in paraffin . Specimens were sectioned (5-um thickness) and stained with hematoxylin and eosin to assess lymphocytic infiltration . Pancreatic beta cells within grafted tissue were identified with anti-insulin antibodies in an indirect peroxidase anti-peroxidase method (DAKO PAP Kit, Accurate Chemical, Westbury, NY) .
Results
Experimental Protocol.
The NOD mouse develops insulitis by 3 mo of age and nearly 70% of female NOD mice become diabetic between 3 and 7 mo of age (1) . In contrast, B10 mice do not display insulitis or develop diabetes . The expression of insulitis and diabetes is recessive since (NOD x B10)Fi mice do not become diabetic or develop insulitis (12) . To ask whether the failure of (NOD x B10)Ft mice to express insulitis and develop diabetes can be attributed to the immune system or whether 
All mice represented in this table were females . Mice were evaluated at the onset of diabetes or at >7 mo old or 7 mo after construction . Chimeras became diabetic between 2 and 10 mo after construction . The average age of NOD mice at the onset of diabetes was 4 mo .
cells from all NOD-'F1 and B10-Ft chimeras tested expressed the class I and class II MHC types of the bone marrow donor.
Expression ofInsulitis and Diabetes in Radiation Bone Marrow Chimeras . Results from chimeras constructed to examine the influence of the experimental manipulations on the development of insulitis and diabetes validated the use of this methodology to study disease development. All NOD-NOD chimeras (n =8) became diabetic 3-7 mo after bone marrow transfer (Table I) , and F1 -F1 and B10-F1 chimeras did not become diabetic and did not display insulitis (Table I) .
Insulitis was observed in 67% (n=24) of NOD-F t chimeras and five of these mice (21%) developed diabetes within 9 mo after construction . From histologic observation, the insulitis seen in NOD-F1 chimeras did not appear to be different from the spontaneous insulitis of NOD mice (Fig. 2 A) . In addition, immunohistochemical analysis ofpancreatic inflammation demonstrated that islet infiltrates were composed primarily of L3T4+ and Lyt-2 + lymphocytes (Fig. 2, B and C . These same cell populations predominate in infiltrated NOD mouse islets (6, 8) . These data demonstrate that NOD bone marrow cells transfer the ability to mount an autoimmune response to the pancreatic (3 cells present in normally nondiabetic (NOD x B10)F1 mice.
Rejection ofNormal Islets by NOD-'Fl Chimeras . To demonstrate that normal pancreatic R cells can be the targets of the autoimmune process present in the NOD mouse, pancreata from B10 and NOD newborn donors were transplanted under the renal capsules of three diabetic and four nondiabetic NOD-F1 chimeras (Table II) . 4-5 wk after transplantation, no insulin-containing p cells were observed in three diabetic recipients (numbers 1-3) that had received B10 and NOD pancreas grafts . Lymphocytic infiltration in the grafts ranged from mild to extensive . Both the NOD and B10 Q cells were rejected in two nondiabetic recipients (numbers 4 and 5) as evidenced by the lack of insulin-positive cells within the islets found in the grafted pancreata . In a third nondiabetic recipient (number 6), the NOD R cells were rejected whereas insulin-positive cells within islets were observed in the B10 graft. Although R cells were observed in the B10 graft in recipient number 6, a high level FIGURE Pancreata from newborn B10 and NOD mice were grafted under the kidney capsules of NOD-F1 chimeras .
. Histology of infiltrated islets of NOD-Fj chimeras . (A) Hematoxylin and eosin staining showing insulitis (x 100) . Immunoperoxidase staining demonstrating (B) L3T4' and (C) Lyt-2' cells within islet infiltrates (x200) .
Recipients were killed 4-5 wk after transplantation . The host pancreas was examined histologically with ( + + + + ) massive insulitis and/or lack of intact islets consistent with overt diabetes and ( + + + ) the presence of moderate to severe insulitis . Grafts were examined for the presence ( + ) or absence ( -) of insulin-containing p cells within defined islets . The level of lymphocytic infiltration within the grafts was scored as follows : ( + ) few infiltrating lymphocytes, ( + + ) moderate infiltration, and ( + + + ) intense infiltration .
of lymphocytic infiltration within the graft (score of + + +) suggests that this graft would have been rejected at a later point in time. A fourth nondiabetic recipient (number 7) failed to reject a cells in either graft since insulin-positive islets were observed under both renal capsules, and only mild to moderate lymphocytic infiltration was observed. As technical controls, syngeneic grafts of BALB/c pancreata to BALB/c recipients and NOD and B10 pancreata to normal (NOD x B10)Fi recipients showed very good islet structure, insulin-positive a cells within the islets, and very few infiltrating lymphocytes (data not shown). In addition, we have previously shown that young NOD mice (5 wk old), which were free of insulitis at the time of analysis, failed to reject the Q cells within pancreas transplants from newborn donors (20) . Therefore, these data, showing that NOD-FI chimeras can reject pancreatic beta cells from newborn B10 mice, indicate that the autoimmune response in the NOD mouse is not specific for a R cell-associated antigen unique to the NOD since R cells in the pancreata of normal B10 mice are also targets of the autoimmune response. Discussion In the current report, we demonstrate that reconstitution of irradiated (NOD x B10)F1 mice with NOD bone marrow cells causes insulitis in a majority of the recipients and diabetes in some. The insulitis in NOD-"F1 chimeras is similar to that observed in the NOD mouse since CD4 and CD8 T cells are observed within the mononuclear cell infiltrates in both cases . In contrast, (NOD x B10)F1 mice reconstituted with bone marrow cells from F t or 1310 mice did not display either insulitis or diabetes . These data strongly suggest that the hematopoietic stem cells of the NOD mouse contribute to the development of insulitis and diabetes and that this genetically determined disease phenotype is not expressed by the hematopoietic stem cells of (NOD x B10)F1 mice. The Fl mouse, however, does express appropriate target tissues for the initiation of the autoimmune process, since transfer of hematopoietic stem cells from NOD mice results in insulitis and diabetes . In addition, we have demonstrated that the effector cells of the autoimmune destruction in the NOD mouse can also recognize the pancreatic a cells from normal B10 mice . Therefore, it is unlikely that an abnormal a cell is a primary cause of diabetes in the NOD mouse. However, it is still possible that although normal islet tissue can be the target of the autoimmune response, tissue present in normal mice may not be able to initiate the autoimmune process. We are currently preparing a congenic mouse strain, B10.H-2 10 D, to address this issue. This strain will be histocompatible with the NOD mouse and will express "normal" tissue (in contrast to the (NOD x B10)F1, which could express a tissue-related diabetogenic phenotype inherited from the NOD). If normal tissue is able to initiate the diabetogenic process in the presence of NOD bone marrow cells, then NOD-B10.H-2 N°D chimeras should develop insulitis and diabetes . The rate ofonset ofdiabetes (2-10 mo after bone marrow reconstitution) observed in both NOD-NOD and NOD-F1 chimeras is consistent with the observation that normal NOD mice do not become diabetic before 3 mo of age. Both in normal mice and in radiation bone marrow chimeras, the maturation of lymphocytes and the development of an autoimmune response must occur before the onset of diabetes. This relatively slow onset of disease contrasts with our previously reported model for the adoptive transfer of diabetes (9) . In this model, diabetes was induced in 4-5-wk-old irradiated NOD mice 2-3 wk after receiving splenic T cells from diabetic donors . We demonstrated that both CD4 and CD8 cells were required to transfer diabetes and that both subsets had to be from "primed" (diabetic) donors .
Our observation that NOD-(NOD x B10)F1 chimeras can reject newborn B10 pancreas grafts is consistent with the findings of Terada et al. (20) that suggest that the effector cells of the autoimmune process in the NOD mouse are restricted by class I gene products and that the target antigens of the autoimmune response are found on the beta cells of normal mice . In the Terada et al . study, diabetic NOD mice, which were treated with cyclosporin to prevent allograft rejection, received transplants ofpancreata from newborn mice with various MHC haplotypes . C57BL/6 (which shares Db with NOD) and BALB/c (which shares K' with NOD) grafts were both rejected, whereas CBA (which has a complete mismatch at the MHC with NOD) grafts were accepted . Thus, the rejection of newborn B10 grafts by NOD-F1 chimeras observed in the current study could be mediated by effector cells restricted by the class I product of the Db locus . The existence of class I-restricted effector cells in the NOD mouse is also supported by the observation that Lyt-2+ T cells (usually class I restricted), in addition to L3T4+ T cells (usually class II restricted), are required to adoptively transfer diabetes in the NOD mouse (9, 10) .
The observation that only 21% of NOD-Fl chimeras became diabetic as opposed to the high incidence (100%) in NOD-NOD control chimeras suggests that the full potential of the NOD bone marrow cells is not reached in the F1 environment . We (12) and others (11, 13) have shown that the genetic control of diabetes in the NOD mouse involves at least three functionally recessive genes, including one linked to the MHC. Thus, the most obvious distinction between F1-and NOD-irradiated recipients is that both H-2N OD and H-26 class I and class II restriction elements are expressed on all appropriate nonhematopoietic tissues in NOD-F, chimeras, whereas in NOD-NOD chimeras only H -2NOD restriction elements are expressed. The presence of non-H-2'(" restriction elements on various cell types may contribute to the less severe autoimmune response observed in NOD-F, chimeras. For example, a lower density of H-2NOD class I antigens on Q cells may make them less susceptible to destruction by class I-restricted effector cells. Alternatively, in NOD-;F, chimeras, radiation-resistant F, APC bearing both H-2b and H-2 NOD MHC antigens, which are present for varying periods oftime after the construction of chimeras (22, 23) , may not be as effective in inducing an autoimmune response as APC that express only H-2 NOD MHC antigens . There is also expression of MHC antigens from both haplotypes on thymic epithelial cells of NOD-}F, chimeras . Thus, thymic learning would be altered and may cause the autoimmune response to be less pronounced (less help, more suppression) in NOD-F, chimeras as compared with NOD-NOD chimeras . Studies with appropriate MHC congenic strains will be needed to address these various alternatives .
In this study, we have demonstrated that the hematopoietic stem cells of the NOD mouse contribute to the development of diabetes . The studies of Ikehara et al. (24) also support this hypothesis since they demonstrated that NOD mice which were lethally irradiated and reconstituted with allogeneic bone marrow cells did not develop insulitis or diabetes . Further experiments to define how the diabetic genotype of the NOD mouse is expressed via the immune system are clearly required. The development ofcongenic strains separating the unlinked diabetogenic loci in the NOD mouse will facilitate the discovery of the underlying mechanisms responsible for the development of diabetes .
Summary
The development ofautoimmune diabetes in the nonobese diabetic (NOD) mouse is controlled by at least three recessive loci, including one linked to the MHC. To determine whether any of these genetic loci exert their effects via the immune system, radiation bone marrow chimeras were constructed in which (NOD x 1310)F,-irradiated recipients were reconstituted with NOD bone marrow cells. Unmanipulated (NOD x B10)F, mice, or irradiated F1 mice reconstituted with F, or B10 bone marrow, did not display insulitis or diabetes . In contrast, insulitis was observed in a majority of the NOD-"F, chimeras and diabetes developed in 21% of the mice . These data demonstrate that expression ofthe diabetic phenotype in the NOD mouse is dependent on NOD-derived hematopoietic stem cells. Diabetogenic genes in the NOD mouse do not appear to function at the level of the insulin-producing a cells since NOD--, chimeras not only developed insulitis and diabetes but also rejected a cells within pancreas transplants from newborn B10 mice . These data suggest that the a cells of the NOD mouse do not express a unique antigenic determinant that is the target of the autoimmune response.
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